Supercom Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on August 3, 2023, reports on a public offering consummated by Supercom Ltd. (the "Company") on the same date. The Company is a foreign private issuer headquartered in Tel Aviv, Israel.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $2.75 million.
- Units Sold: 3,235,295 units.
- Offering Price: $0.85 per Unit.
- Placement Agent Fee: 7.0% of gross proceeds (approximately $192,500).
- Unit Composition: Each Unit consists of one ordinary share (or one Pre-Funded Warrant) and one Warrant exercisable at $0.85 per share.
- Warrant Terms: New Warrants are immediately exercisable and expire five years from issuance. Pre-Funded Warrants are immediately exercisable with an exercise price of $0.00001.
Note: This filing does not provide data on revenue, profit, cash flow, operating margins, total debt, or liquidity positions.
Material Changes and Agreements
- Securities Purchase Agreement: Entered into on August 2, 2023, with an institutional investor. Includes a 60-day lock-up period restricting the issuance of new ordinary shares or equivalents.
- Warrant Amendment: The Company amended existing warrants held by the Purchaser (covering up to 2,082,484 shares issued previously) to reduce the exercise price to $0.85 per share and extend the termination date to August 3, 2028.
- Registration: The offering was conducted under a Registration Statement on Form S-1 declared effective by the SEC on August 2, 2023.
Outlook, Risks, and Management Commentary
The filing focuses on the mechanics of the capital raise and does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard contractual representations and warranties. The Company has agreed to customary indemnification obligations and termination provisions in the transaction agreements.
Key Facts for Investor Verification
- Verify the net proceeds after deducting the 7.0% placement agent fee and reimbursed expenses.
- Confirm the dilution impact of the 3,235,295 new units and the amendment of 2,082,484 existing warrants.
- Review the 60-day lock-up restrictions on future equity issuances detailed in the Securities Purchase Agreement.
- Check the Company's current cash balance to assess how the $2.75 million gross proceeds impact immediate liquidity.